Abstract
Neuropeptide Y (NPY) is a 36-amino acid peptide with structural similarities to peptide YY (PYY) and pancreatic polypeptide (PP). NPY, one of the most abundant neuropeptides known, is widely distributed throughout the central and peripheral nervous systems, while PYY and PP are predominantly distributed in the endocrine cells of the intestine and pancreas, respectively. Five NPY receptor subtypes denoted as Y1, Y2, Y4, Y5, and y6 mediate the actions of NPY. NPY is involved in the regulation of diverse functions including food intake, blood pressure, circadian rhythms, stress, pain, hormone secretion, reproduction, and alcohol consumption. NPY has also been implicated in the pathophysiology of a number of diseases such as feeding disorders, seizures, hypertension, pain disorders, depression, and anxiety. This review will describe a brief history and an overview of the studies on NPY concerning the isolation, tissue distribution, receptor subtypes, receptor agonists and antagonists, physiological functions, and pharmacological activities.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adrian TE, Allen JM, Bloom SR et al. (1983) Neuropeptide Y distribution in human brain. Nature 306:584–586
Aicher SA, Springston M, Berger SB et al. (1991) Receptor-selective analogs demonstrate NPY/PYY receptor heterogeneity in rat brain. Neurosci Lett 130:32–36
Albers HE, Ferris CF (1984) Neuropeptide Y: role in light-dark cycle entrainment of hamster circadian rhythms. Neurosci Lett 50:163–168
Allen JM, Adrian TE, Tatemoto K et al. (1982) Two novel related peptides, neuropeptide Y (NPY) and peptide YY (PYY) inhibit the contraction of the electrically stimulated mouse vas deferens. Neuropeptides 3:71–77
Allen JM, Rodrigo J, Yeats JC et al. (1984) Vascular distribution of neuropeptide Y (NPY) and effect on blood pressure. Clin Exp Hypertens A 6:1879–1882
Allen YS, Adrian TE, Allen JM et al. (1983) Neuropeptide Y distribution in the rat brain. Science 221:877–879
Balasubramaniam AA (1997) Neuropeptide Y family of hormones: receptor subtypes and antagonists. Peptides 18:445–457
Baraban SC, Hollopeter G, Erickson JC et al. (1997) Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J Neurosci 17:8927–8936
Bard JA, Walker MW, Branchek TA, Weinshank RL (1995) Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY. J Biol Chem 270:26762–26765
Batterham RL, Cowley MA, Small CJ et al. (2002) Gut hormone PYY(3–36) physiologically inhibits food intake. Nature 418:650–654
Beck A, Jung G, Gaida W et al. (1989) Highly potent and small neuropeptide Y agonist obtained by linking NPY 1–4 via spacer to alpha-helical NPY 25–36. FEBS Lett 244:119–122
Boublik J, Scott N, Taulane J et al. (1989) Neuropeptide Y and neuropeptide Y18–36. Structural and biological characterization. Int J Pept Protein Res 33:11–15
Burkhoff A, Linemeyer DL, Salon JA (1998) Distribution of a novel hypothalamic neuropeptide Y receptor gene and it’s absence in rat. Brain Res Mol Brain Res 53:311–316
Caberlotto L, Fuxe K, Overstreet DH et al. (1998) Alterations in neuropeptide Y and Y1 receptor mRNA expression in brains from an animal model of depression: region specific adaptation after fluoxetine treatment. Brain Res Mol Brain Res 59:58–65
Caberlotto L, Fuxe K, Hurd YL (2000) Characterization of NPY mRNA-expressing cells in the human brain: co-localization with Y2 but not Y1 mRNA in the cerebral cortex, hippocampus, amygdala, and striatum. J Chem Neuroanat 20:327–337
Chen X, Westfall TC (1993) Depressor effect of intrathecal neuropeptide Y (NPY) is mediated by Y2 subtype of NPY receptors. J Cardiovasc Pharmacol 21:720–724
Chronwall BN, DiMaggio, DA, Massari VJ et al. (1985) The anatomy of neuropeptide Y-containing neurons in rat brain. Neuroscience 15:1159–1181
Clark JT, Kalra PS, Crowley WR, Kalra SP (1984) Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115:427–429
Clark JT, Kalra PS, Kalra SP (1985) Neuropeptide Y stimulates feeding but inhibits sexual behavior in rats. Endocrinology 117:2435–2442
Colmers WF, Lukowiak K, Pittman Q (1988) Neuropeptide Y action in the rat hippocampal slice: site and mechanism of presynaptic inhibition. J Neurosci 8:3827–337
Colmers WF, Klapstein GJ, Fournier A et al. (1991) Presynaptic inhibition by neuropeptide Y in rat hippocampal slice in vitro is mediated by a Y2 receptor. Br J Pharmacol 102:41–44
Corder R, Emson PC, Lowry PJ (1984) Purification and characterization of human neuropeptide Y from adrenal-medullary phaeochromocytoma tissue. Biochem J 219:699–706
Edvinsson L, Emson P, McCulloch J et al. (1983) Neuropeptide Y: cerebrovascular innervation and vasomotor effects in the cat. Neurosci Lett 43:79–84
Erickson JC, Clegg KE, Palmiter RD (1996) Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381:415–421
Evequoz D, Waeber B, Aubert JF et al. (1988) Neuropeptide Y prevents the blood pressure fall induced by endotoxin in conscious rats with adrenal medullectomy. Circ Res 62:25–30
Everitt BJ, Hokfelt T (1989) The existence of neuropeptide Y with other peptides and amines in the central nervous system. In: Mutt V et al. (eds) Neuropeptide Y. Raven Press, New York, pp 61–71
Ewald DA, Sternweis PC, Miller RJ (1988) Guanine nucleotide-binding protein Go-induced coupling of neuropeptide Y receptors to Ca2+ channels in sensory neurons. Proc Natl Acad Sci USA 85:3633–3637
Flood JF, Hernandez EN, Morley JE (1987) Modulation of memory processing by neuropeptide Y. Brain Res 421:280–290
Fredholm BB, Jansen I, Edvinsson L (1985) Neuropeptide Y is a potent inhibitor of cyclic AMP accumulation in feline cerebral blood vessels. Acta Physiol Scand 124:467–469
Fuhlendorff I, Gether U, Aakerlund L et al. (1990) [Leu31, Pro34] neuropeptide Y: a specific Y1 receptor agonist. Proc Natl Acad Sci USA 87:182–186
Fukuhara C, Brewer JM, Dirden JC et al. (2001) Neuropeptide Y rapidly reduces Period 1 and Period 2 mRNA levels in the hamster suprachiasmatic nucleus. Neurosci Lett 314:119–122
Furtinger S, Pirker S, Czech T et al. (2001) Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy. J Neurosci 21:5804–5812
Fuxe K, Agnati LF, Harfstrand A et al. (1983) Central administration of neuropeptide Y induces hypotension bradypnea and EEG synchronization in the rat. Acta Physiol Scand 118:189–192
Gehlert DR, Chronwall BM, Schafer MP, O’Donohue TL (1987) Localization of neuropeptide Y messenger ribonucleic acid in rat and mouse brain by in situ hybridization. Synapse 1:25–31
Gehlert DR, Beavers LS, Johnson D et al. (1996) Expression cloning of a human brain neuropeptide Y Y2 receptor. Mol Pharmacol 49:224–228
Gerald C, Walker MW, Vaysse PJ et al. (1995) Expression cloning and pharmacological characterization of a human hippocampal neuropeptide Y/peptide YY Y2 receptor subtype. J Biol Chem 270:26758–26761
Gerald C, Walker MW, Criscione L et al. (1996) A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 382:168–171
Golombek DA, Biello SM, Rendon RA, Harrington ME (1996) Neuropeptide Y phase shifts the circadian clock in vitro via a Y2 receptor. Neuroreport 7:1315–1319
Gregor P, Millham ML, Feng Y et al. (1996) Cloning and characterization of a novel receptor to pancreatic polypeptide, a member of the neuropeptide Y receptor family. FEBS Lett 381:58–62
Hackenthal E, Aktories K, Jakobs KH, Lang RE (1987) Neuropeptide Y inhibits renin release by a pertussis toxin-sensitive mechanism. Am J Physiol 252:F543–F550
Heilig M, Murison R (1987) Intracerebroventricular neuropeptide Y protects against stress-induced gastric erosion in the rat. Eur J Pharmacol 137:127–129
Heilig M, Wahlestedt C, Ekman R, Widerlov E (1988) Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain. Eur J Pharmacol 147:465–467
Heilig M, Soderpalm B, Engel JA, Widerlov E (1989) Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology (Berlin) 98:524–529
Heilig M, McLeod S, Brot M et al. (1993) Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology 8:357–363
Hellstrom PM, Olerup O, Tatemoto K (1985) Neuropeptide Y may mediate effects of sympathetic nerve stimulations on colonic motility and blood flow in the cat. Acta Physiol Scand 124:613–624
Herzog H, Hort YJ, Ball H et al. (1992) Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc Natl Acad Sci USA 89:5794–5798
Herzog H, Hort YJ, Shine J, Selbie LA (1993) Molecular cloning, characterization, and localization of the human homolog to the reported bovine NPY Y3 receptor: lack of NPY binding and activation. DNA Cell Biol 12:465–471
Hokfelt T, Lundberg JM, Lagercrantz H et al. (1983) Occurrence of neuropeptide Y (NPY)-like immunoreactivity in catecholamine neurons in the human medulla oblongata. Neurosci Lett 36:217–222
Hu Y, Bloomquist BT, Cornfield LJ et al. (1996) Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior. J Biol Chem 271:26315–26319
Hua XY, Boublik JH, Spicer MA et al. (1991) The antinociceptive effects of spinally administered neuropeptide Y in the rat: systematic studies on structure-activity relationship. J Pharmacol Exp Ther 258:243–248
Huhman KL, Gillespie CF, Marvel CL, Albers HE (1996) Neuropeptide Y phase shifts circadian rhythms in vivo via a Y2 receptor. Neuroreport 7:1249–1252
Inui A, Okita M, Nakajima M et al. (1998) Anxiety-like behavior in transgenic mice with brain expression of neuropeptide Y. Proc Assoc Am Physicians 110:171–182
Jazin EE, Yoo H, Blomqvist AG et al. (1993) A proposed bovine neuropeptide Y (NPY) receptor cDNA clone, or its human homologue, confers neither NPY binding sites nor NPY responsiveness on transfected cells. Regul Pept 47:247–258
Kalra SP, Crowley WR (1984) Norepinephrine-like effects of neuropeptide Y on LH release in the rat. Life Sci 35:1173–1176
Kalra SP, Fuentes M, Fournier A et al. (1992) Involvement of the Y-l receptor subtype in the regulation of luteinizing hormone secretion by neuropeptide Y in rats. Endocrinology 130:3323–3330
Kanatani A, Mashiko S, Murai N et al. (2000) Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice. Endocrinology 141:1011–1016
Kassis S, Olasmaa M, Terenius L, Fishman PH (1987) Neuropeptide Y inhibits cardiac adenylate cyclase through a pertussis toxin-sensitive G protein. J Biol Chem 262:3429–3431
Kaye WH, Berrettini W, Gwirtsman H, George DT (1990) Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa. Arch Gen Psychiatry 47:548–556
Klapstein GJ, Colmers WF (1997) Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro. J Neurophysiol 78:1651–1661
Krause J, Eva C, Seeburg PH, Sprengel R (1992) Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor. Mol Pharmacol 41:817–821
Krstenansky JL, Owen TJ, Buck SH et al. (1989) Centrally truncated and stabilized porcine neuropeptide Y analogs: design, synthesis, and mouse brain receptor binding. Proc Natl Acad Sci USA 86:4377–4381
Kushi A, Sasai H, Koizumi H et al. (1998) Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice. Proc Natl Acad Sci USA 95:15659–15664
Larhammar D, Blomqvist AG, Yee F et al. (1992) Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. J Biol Chem 267:10935–10938
Larhammar D, Blomqvist AG, Soderberg C (1993) Evolution of neuropeptide Y and its related peptides. Comp Biochem Physiol 106 C:743–752
Leibowitz SF, Alexander JT (1991) Analysis of neuropeptide Y-induced feeding: dissociation of Y1 and Y2 receptor effects on natural meal patterns. Peptides 12:1251–1260
Leibowitz SF, Xuereb M, Kim T (1992) Blockade of natural and neuropeptide Y-induced carbohydrate feeding by a receptor antagonist PYX-2. Neuroreport 3:1023–1026
Levine AS, Morley JE (1984) Neuropeptide Y: a potent inducer of consummatory behavior in rats. Peptides 5:1025–1029
Lundberg JM, Tatemoto K (1982) Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade. Acta Physiol Scand 116:393–402
Lundberg JM, Terenius L, Hokfelt T et al. (1982) Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand 116:477–480
Lundberg JM, Terenius L, Hokfelt T, Goldstein M (1983) High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci Lett 42:167–172
Lundberg JM, Stjarne L (1984) Neuropeptide Y (NPY) depresses the secretion of 3H-noradrenaline and the contractile response evoked by field stimulation, in rat vas deferens. Acta Physiol Scand 120:477–479
Lundell I, Blomqvist AG, Berglund MM et al. (1995) Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J Biol Chem 270:29123–29128
MacDonald JK (1988) NPY and related substances. Crit Rev Neurobiol 4:97–135
Malmstrom RE (2001) Vascular pharmacology of BIIE0246, the first selective non-peptide neuropeptide Y Y(2) receptor antagonist, in vivo. Br J Pharmacol 133:1073–1080
Malmstrom RE, Lundberg JM (1995) Neuropeptide Y accounts for sympathetic vasoconstriction in guinea-pig vena cava: evidence using BIBP 3226 and 3435. Eur J Pharmacol 294:661–668
Marksteiner J, Sperk G (1988) Concomitant increase of somatostatin, neuropeptide Y and glutamate decarboxylase in the frontal cortex of rats with decreased seizure threshold. Neuroscience 26:379–385
Marksteiner J, Prommegger R, Sperk G (1990) Effect of anticonvulsant treatment on kainic acid-induced increases in peptide levels. Eur J Pharmacol 81:241–246
Marsh DJ, Hollopeter G, Kafer KE, Palmiter RD (1998) Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nature Med 4:718–721
Marsh DJ, Baraban SC, Hollopeter G, Palmiter RD (1999) Role of the Y5 neuropeptide Y receptor in limbic seizures. Proc Natl Acad Sci USA 96:13518–13523
Martel JC, St-Pierre S, Quirion R (1986) Neuropeptide Y receptors in rat brain: autoradiographic localization. Peptides 7:55–60
Matsumoto M, Nomura T, Momose K et al. (1996) Inactivation of a novel neuropeptide Y/peptide YY receptor gene in primate species. J Biol Chem 271:27217–27220
Michel MC, Beck-Sickinger A, Cox H et al. (1998) XVI International union of pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50:143–150
Minth CD, Bloom SR, Polak JM, Dixon JE (1984) Cloning, characterization, and DNA sequence of a human cDNA encoding neuropeptide tyrosine. Proc Natl Acad Sci USA 81:4577–4581
Minth CD, Andrews PC, Dixon JE (1986) Characterization, sequence, and expression of the cloned human neuropeptide Y gene. J Biol Chem 261:11974–11979
Morioka H, Inui A, Inoue T et al. (1986) Neuropeptide Y decreases rectal temperature after intracerebroventricular administration in conscious dogs. Kobe J Med Sci 32:45–57
Motulsky HJ, Michel MC (1988) Neuropeptide Y mobilizes Ca2+ and inhibits adenylate cyclase in human erythroleukemia cells. Am J Physiol 255:E880–885
Nakajima M, Inui A, Asakawa A et al. (1998) Neuropeptide Y produces anxiety via Y2-type receptors. Peptides 19:359–363
Naveilhan P, Hassani H, Canals JM et al. (1999) Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor. Nature Med 5:1188–1193
Naveilhan P, Hassani H, Lucas G et al. (2001) Reduced antinociception and plasma extravasation in mice lacking a neuropeptide Y receptor. Nature 409:513–517
Parker RM, Herzog H. (1999) Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur J Neurosci 11:1431–1448
Parker EM, Babij CK, Balasubramaniam A et al. (1998) GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Yare potent neuropeptide Y Y1 receptor antagonists and neuropeptide Y Y4 receptor agonists. Eur J Pharmacol 349:97–105
Parker E, Van Heek M, Stamford A (2002) Neuropeptide Y receptors as targets for antiobesity drug development: perspective and current status. Eur J Pharmacol 440:173–187
Pedrazzini, Seydoux, Kunstner et al. (1998) Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor. Nature Med 4:722–726
Petty MA, Dietrich R, Lang RE (1984) The cardiovascular effects of neuropeptide Y (NPY). Clin Exp Hypertens A 6:1889–1892
Pheng LH, Regoli D (2000) Receptors for NPY in peripheral tissues bioassays. Life Sci 67:847–862
Pralong FP, Gonzales C, Voirol MJ et al. (2002) The neuropeptide Y Y1 receptor regulates leptin-mediated control of energy homeostasis and reproductive functions. FASEB J 16:712–714
Raposinho PD, Broqua P, Pierroz DD et al. (1999) Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype. Endocrinology 140:4046–4055
Rimland J, Xin W, Sweetnam P et al. (1991) Sequence and expression of a neuropeptide Y receptor cDNA. Mol Pharmacol 40:869–875
Rimland JM, Seward EP, Humbert Y et al. (1996) Coexpression with potassium channel subunits used to clone the Y2 receptor for neuropeptide Y. Mol Pharmacol 49:387–390
Rose PM, Fernandes P, Lynch JS et al. (1995) Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J Biol Chem 270:22661–22664
Rudolf K, Eberlein W, Engel W et al. (1994) The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226. Eur J Pharmacol 271:R11–13
Sainsbury A, Schwarzer C, Couzens M et al. (2002) Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice. Proc Natl Acad Sci USA 99:8938–8943
Sheikh SP, O’Hare MM, Tortora O, Schwartz TW (1989) Binding of monoiodinated neuropeptide Y to hippocampal membranes and human neuroblastoma cell lines. J Biol Chem 264:6648–6654
Stanley BG, Leibowitz SF (1984) Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci 35:2635–2642
Statnick MA, Schober DA, Gackenheimer S et al. (1998) Characterization of the neuropeptide Y5 receptor in the human hypothalamus: a lack of correlation between Y5 mRNA levels and binding sites. Brain Res 810:16–26
Stephens TW, Basinski M, Bristow PK et al. (1995) The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377:530–532
Sun XY, Zhao XH, Erlinge D et al. (1996) Effects of phosphorothioated neuropeptide Y Y1-receptor antisense oligodeoxynucleotide in conscious rats and in human vessels. Br J Pharmacol 118:131–136
Sundler F, Moghimzadeh E, Hakanson R et al. (1983) Nerve fibers in the gut and pancreas of the rat displaying neuropeptide-Y immunoreactivity. Intrinsic and extrinsic origin. Cell Tissue Res 230:487–493
Tatemoto K (1982a) Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci USA 79:5485–5489
Tatemoto K (1982b) Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc Natl Acad Sci USA 79:2514–2518
Tatemoto K (1990) Neuropeptide Y and its receptor antagonist. Ann New York Acad Sci. 611:1–6
Tatemoto K, Mutt V (1978) Chemical determination of polypeptide hormones. Proc Natl Acad Sci USA 75:4115–4119
Tatemoto K, Mutt V (1980) Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides. Nature 285:417–418
Tatemoto K, Carlquist M, Mutt V (1982) Neuropeptide Y—a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296:659–660
Tatemoto K, Rokaeus A, Jornvall H et al. (1983) Galanin—a novel biologically active peptide from porcine intestine. FEBS Lett 164:124–128
Tatemoto K, Lundberg JM, Jornvall H, Mutt V (1985) Neuropeptide K: Isolation, structure and biological activities of a novel brain tachykinin. Biochem Biophys Res Commun 128:947–953
Tatemoto K, Efendic S, Mutt V et al. (1986) Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 324:476–478
Terenghi G, Polak JM, Hamid Q et al. (1987) Localization of neuropeptide Y mRNA in neurons of human cerebral cortex by means of in situ hybridization with a complementary RNA probe. Proc Natl Acad Sci USA 84:7315–7318
Thiele TE, Marsh DJ, Ste Marie L et al. (1998) Ethanol consumption and resistance are inversely related to NPY levels. Nature 396:366–369
Thiele TE, Koh MT, Pedrazzini T (2002) Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor. J Neurosci 22:RC208:l–6
Thorsell A, Michalkiewicz M, Dumont Y et al. (2000) Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci USA 97:12852–12857
Thorsell A, Rimondini R, Heilig M. (2002) Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in rats. Neurosci Lett 332:1–4
Toufexis DJ, Kyriazis D, Woodside B (2002) Chronic neuropeptide Y Y5 receptor stimulation suppresses reproduction in virgin female and lactating rats. J Neuroendocrinol 14:492–497
Unden A, Tatemoto K, Mutt V, Bartfai T (1984) Neuropeptide Y receptor in the rat brain. Eur J Biochem 145: 525–530
Vezzani A, Michalkiewicz M, Michalkiewicz T et al. (2002) Seizure susceptibility and epileptogenesis are decreased in transgenic rats overexpressing neuropeptide Y. Neuroscience 110:237–243
Wahlestedt C, Yanaihara N, Hakanson R (1986) Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides. Regul Pept 13:307–318
Wahlestedt C, Pich EM, Koob GF, Yee F, Heilig M (1993) Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science 259:528–531
Watson JD, Sury MR, Corder R et al. (1988) Plasma levels of neuropeptide tyrosine Y (NPY) are increased in human sepsis but are unchanged during canine endotoxin shock despite raised catecholamine concentrations. J Endocrinol 116:421–426
Weinberg DH, Sirinathsinghji DJ, Tan CP et al. (1996) Cloning and expression of a novel neuropeptide Y receptor. J Biol Chem 271:16435–16438
Westrin A, Ekman R, Traskman-Bendz L (1999) Alterations of corticotropin releasing hormone (CRH) and neuropeptide Y (NPY) plasma levels in mood disorder patients with a recent suicide attempt. Eur Neuropsychopharmacol 9:205–211
Wharton J, Gordon L, Byrne J et al. (1993) Expression of the human neuropeptide tyrosine Y1 receptor. Proc Natl Acad Sci USA 90:687–691
Widerlov E, Lindstrom LH, Wahlestedt C, Ekman R (1988) Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively. J Psychiatr Res 22:69–79
Woldbye DP, Larsen PJ, Mikkelsen JD et al. (1997) Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors. Nature Med 3:761–764
Yan H, Yang J, Marasco J et al. (1996) Cloning and functional expression of cDNAs encoding human and rat pancreatic polypeptide receptors. Proc Natl Acad Sci USA 93:4661–4665
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Tatemoto, K. (2004). Neuropeptide Y: History and Overview. In: Michel, M.C. (eds) Neuropeptide Y and Related Peptides. Handbook of Experimental Pharmacology, vol 162. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18764-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-18764-3_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62282-3
Online ISBN: 978-3-642-18764-3
eBook Packages: Springer Book Archive